Laverock Therapeutics

Private

LondonHealthcare & Life Scienceshttps://www.laverocktx.com/

Last Round

Grant

Jun 1, 2026

Total Funding Raised

$30.86M

Company Overview

Laverock Therapeutics is a biotechnology company that develops a gene silencing platform designed to engineer programmable and adaptive cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

gene silencingGEiGScell therapygene therapyprogrammable medicineCAR-TiPSC-derived macrophagesynthetic biologyprecision medicinedrug discoverybiotech platformin vivo gene therapynext-gen therapeuticsAI-augmented drug discoverybiopharma partnership

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Laverock Therapeutics Comparables

Compare Laverock Therapeutics with similar companies based on industry and business-model similarity.

Laverock Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Laverock Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jun 1, 2026
Seed	Jun 30, 2025
Grant	Oct 30, 2023
Seed	Sep 28, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Lisa Deschamps

Chief Executive Officer Board Member

Executive Team

Tim Allsopp

CTO P T

Executive Team

Sandy McDougall

Chief Financial Officer

Executive Team

Tom Payne

Chief Operating Officer

Executive Team

View all key people

Laverock Therapeutics Investors

Notable investors and investment history

Laverock Therapeutics investors
Investor	Rounds
Future Planet Capital Regional	Seed, Grant
Mercia Ventures	Seed
Tekfen Ventures	Seed
Innovate UK	Grant
UK Innovation & Science Seed Fund	Grant
Calculus Capital	Seed
Eos Advisory	Seed

View all Investors

Laverock Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Laverock Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Laverock Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Employee Range35

Year Founded2021

Last FundingJun 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.